SS
ZYME icon

Steve Schonfeld’s Zymeworks ZYME Stock Holding History

Steve Schonfeld’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-288,571
Closed -$7.6M – 2755
2025
Q4 		$7.6M Buy
288,571
+180,783
+168% +$3.94M 0.03% 426
2025
Q3 		$1.84M Buy
+107,788
New +$1.54M 0.01% 1078
2025
Q2 		– Sell
-21,900
Closed -$261K – 2622
2025
Q1 		$261K Sell
21,900
-900
-4% -$12.3K ﹤0.01% 1849
2024
Q4 		$334K Buy
+22,800
New +$319K ﹤0.01% 1570
2022
Q2 		– Sell
-75,200
Closed -$493K – 3076
2022
Q1 		$493K Buy
+75,200
New +$670K ﹤0.01% 1382
2021
Q2 		– Sell
-16,817
Closed -$531K – 2371
2021
Q1 		$531K Buy
+16,817
New +$683K 0.01% 1117
2020
Q4 		– Sell
-23,353
Closed -$1.09M – 1931
2020
Q3 		$1.09M Buy
23,353
+17,163
+277% +$589K 0.02% 680
2020
Q2 		$223K Buy
+6,190
New +$228K 0.01% 1074
2019
Q3 		– Sell
-79,200
Closed -$1.74M – 1283
2019
Q2 		$1.74M Buy
+79,200
New +$1.45M 0.06% 318

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Steve Schonfeld's ZYME Position: Q1 2026 in Review

Steve Schonfeld sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 288,571 shares — an estimated $7.6M sold.

Steve Schonfeld first reported a position in ZYME in Q2 2019 and held it in 9 quarters. The position peaked at $7.6M in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Steve Schonfeld reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
  • Steve Schonfeld sold 288,571 Zymeworks shares in Q1 2026, an estimated $7.6M.
  • Steve Schonfeld first reported a position in Zymeworks in Q2 2019 and held it in 9 quarters.
  • Steve Schonfeld's Zymeworks position peaked at $7.6M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.